Different Forms of Ischemic Heart Diseases and Separate Components of Metabolic Syndrome
DOI:
https://doi.org/10.51699/ijhsms.v2i12.3218Keywords:
Cardiac Ischemia, Hyperlipidemia, Increased Glucose Tolerance, Obesity, Metabolic SyndromeAbstract
Coronary heart disease (CHD) is one of the most significant medical and social problems of modern medicine. This is due to the widespread prevalence of this disease and high disability and mortality due to coronary heart disease.One of the most promising ways to combat IHD is prevention based on the timely identification and elimination of various risk factors (RF) for this disease. The work uses modern methods recommended by WHO for population studies.A representative sample of 1335 people from the unorganized male population of 20-69 years of the city of Bukhara was examined. The research program included a survey on a standard WHO questionnaire to identify angina pectoris and myocardial infarction, as well as ECG recording. Electrocardiography was performed at rest on the 6-NEK electrocardiograph in 12 common leads. According to the data obtained, the frequency of various manifestations of coronary heart disease in the structure of all cases of coronary heart disease among individuals with various RF is ambiguous (see table). On the contrary, the prevalence of the painless form of coronary heart disease was greatest among individuals who had a combination of all four of the considered RFs, and least often this form of coronary heart disease was found among people without RF. So the frequency of cases of myocardial infarction (1 case) among people with MS was more than 4 times higher than among people without RF (1 case), however, these differences were not statistically significant. The results of a population study in Tashkent indicate that the presence of NTG and metabolic syndrome leads to a violation of the typical clinical picture of IHD - [5].
Downloads
References
Жураева Х.И., Турсунова Д.Э. Встречаемость компонентов метаболического синдрома в практике экстренной медицинской помощи // Биология и интегративная медицина 2019 №3 (31) стр.43-50.
Бахриддиновна Р.Д., Шавкат кызы В.С. (2023). Метаболический синдром и фармакоэкономика (обзор). ЕВРОПЕЙСКИЙ ЖУРНАЛ ИННОВАЦИЙ В НЕФОРМАЛЬНОМ ОБРАЗОВАНИИ, 3 (3), 69–74. Получено с https://inovatus.es/index.php/ejine/article/view/1531.
Ash-Bernal R., Peterson L.R. The cardiometabolic syndrome and cardiovascular disease. J Cardiometab Syndr 2016; 1:25-28.
Umetani K., Kodama Y., Nakamura T. et al. High Prevalence of Paroxysmal Atrial Fibrillation and/or Atrial Flutter in Metabolic Syndrome. Circ J 2015; 71:252-255.
H.Watanabe, N.Tanabe, T.Watanabe et al. Metabolic Syndrome and Risk of Development of Atrial Fibrillation. The Niigata Preventive Medicine Study. Circulation 2014; 117: I255-1260.
Nicolaou V.N., Papadakis J.E., Karatzis F.N. et al. Impact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation. Angiology 2016; 58 (1):21-25.
Echahidi N., Mohty D., Pibarot P. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation 2016; 116 (11): I213-1219.
Alpert M.A. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2016; 321 (4):225-236.
Lown B., Verrier R.L. Neural activity and ventricular fibrillation. N Engl J Med 2014; 294(21):1165-1170.
Verrier R.L., Antzelevitch C. Autonomic aspects of arrhythmogenesis: the enduring and the new. CurrOpinCardiol 2012;19(1):2-11.
Park S.K., Schwartz J., Weisskopf M. et al. Low-Level Lead Exposure, Metabolic Syndrome, and Heart Rate Variability: The VA Normative Aging Study. Environ Health Perspect 2014; 114(11):17181724.
Guidelines for the Management of Arterial Hypertension. EHJ 2017; 28: 1462-1536.